MCB Try AEM online
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, K.-N.
Right arrow Articles by Frazer, I. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, K.-N.
Right arrow Articles by Frazer, I. H.
Molecular and Cellular Biology, October 2005, p. 8643-8655, Vol. 25, No. 19
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.19.8643-8655.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Gene Codon Composition Determines Differentiation-Dependent Expression of a Viral Capsid Gene in Keratinocytes In Vitro and In Vivo

Kong-Nan Zhao,* WenYi Gu, Ning Xia Fang, Nicholas A. Saunders, and Ian H. Frazer*

Centre for Immunology and Cancer Research, The University of Queensland, Research Extension, Building 1, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland 4102, Australia

Received 18 March 2005/ Returned for modification 28 April 2005/ Accepted 11 July 2005


   ABSTRACT
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
By establishing mouse primary keratinocytes (KCs) in culture, we were able, for the first time, to express papillomavirus major capsid (L1) proteins by transient transfection of authentic or codon-modified L1 gene expression plasmids. We demonstrate in vitro and in vivo that gene codon composition is in part responsible for differentiation-dependent expression of L1 protein in KCs. L1 mRNA was present in similar amounts in differentiated and undifferentiated KCs transfected with authentic or codon-modified L1 genes and had a similar half-life, demonstrating that L1 protein production is posttranscriptionally regulated. We demonstrate further that KCs substantially change their tRNA profiles upon differentiation. Aminoacyl-tRNAs from differentiated KCs but not undifferentiated KCs enhanced the translation of authentic L1 mRNA, suggesting that differentiation-associated change to tRNA profiles enhances L1 expression in differentiated KCs. Thus, our data reveal a novel mechanism for regulation of gene expression utilized by a virus to direct viral capsid protein expression to the site of virion assembly in mature KCs. Analysis of two structural proteins of KCs, involucrin and keratin 14, suggests that translation of their mRNAs is also regulated, in association with KC differentiation in vitro, by a similar mechanism.


   INTRODUCTION
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Direction of gene expression to undifferentiated or differentiated cells is classically determined by altered promoter methylation or by production of specific transcription factors or posttranscriptionally by interaction of regulatory mRNA sequences with translational regulators (38). Papillomaviruses (PVs) are a family of double-stranded DNA viruses which replicate exclusively in epithelium, promote cell growth, and affect cellular differentiation, giving rise to benign tumors with, for some virus types, potential for malignancy. mRNA encoding the PV major capsid L1 protein can be transcribed from L1 gene expression plasmids in many types of mammalian cells (20). However, translation of the transcribed mRNA to L1 protein is limited in vivo to differentiated keratinocytes (KCs) (5, 53) and to yeast cells (50, 67). Although inhibitory mechanisms have been proposed to explain the blockage of PV L1 gene translation in undifferentiated cells (10, 11), no inhibitory factors have been identified as specific for epithelial cells in vitro or in vivo. Thus, the mechanism for the tight differentiation-specific translation of the PV L1 gene in KCs remains to be determined.

PVs, like many mammalian DNA viruses, use relatively few "mammalian consensus" codons to encode their capsid genes, manifesting a high A+T genome content due to third-nucleotide bias to A+T (68). In humans, codon-mediated translational controls may play an important role in the differentiation and regulation of tissue-specific gene products (47). Blockage to translation of PV L1 mRNAs has been overcome by codon modification utilizing mammalian preferred codons without changing the protein sequence (36, 41, 42, 69), but it remains unclear whether codon modification assists L1 protein synthesis by removal of sequences inhibitory to mRNA translation or destabilizing of mRNA or by some other mechanism. Mechanisms postulated to determine instability of L1 mRNA in undifferentiated cells (32, 54, 62) have not been demonstrated to distinguish between undifferentiated and differentiated KCs, the host cells of PV infection.

Terminally differentiated KCs flatten and develop a cornified envelope, which provides the barrier function of epithelia (1). The proliferation and differentiation capacity of cultured epidermal cells makes KCs ideal candidates for gene targeting and drug therapy (35). It is therefore desirable to develop models for the study of regulation of gene expression in KCs as they develop. In this study, we examined expression of the PV major capsid (L1) proteins from authentic or codon-modified (Mod) L1 gene expression plasmids in KC culture in vitro and in mouse skin in vivo. We demonstrate that gene codon composition determines the timing of PV L1 capsid protein expression in KC culture in vitro upon differentiation and the differential expression of the L1 gene between the superficial and basal epithelium of the skin in vivo. Substantial differences were demonstrated in the tRNA pools of differentiated and undifferentiated KCs. A change in the aminoacyl-tRNA (aa-tRNA) pool upon KC differentiation enhances translation of authentic but not Mod PV L1 mRNA, likely reflecting a better match in differentiated KCs between available aa-tRNAs and the codons present in the PV L1 gene but rarely used in most mammalian genes.


   MATERIALS AND METHODS
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Construction of native (Nat) and Mod PV L1 genes. The plasmids used in the experiments described here (pCDNA3HPV6b Nat L1, pCDNA3HPV6b Mod L1, pCDNA3BPV1 Nat L1, and pCDNA3BPV1 Mod L1) have previously been described (69). Briefly, both the bovine PV 1 (BPV1) and human PV 6b (HPV6b) wild-type L1 open reading frames (ORFs) are about 1.5 kb in length, encoding ~500 amino acids. The PV wild-type L1 genes show a strong codon usage bias, among degenerately encoded amino acids, toward 18 codons mainly with T at the third position that are rarely used by mammalian genes (68, 69). We artificially modified BPV1 and HPV6b L1 genes in which the L1 ORFs are substituted with codons preferentially used in the mammalian genome. We made about 250 base substitutions in 250 codons rarely used in mammalian cells to produce unmodified L1 proteins encoded from the L1 ORFs with consensus codon usage (69). All the Nat and Mod PV L1 sequences were sequenced and found to be error free; they were then cloned into the mammalian expression vector pCDNA3 containing simian virus 40 ori (Invitrogen), giving four expression plasmids, pCDNA3HPV6b Nat L1, pCDNA3HPV6b Mod L1, pCDNA3BPV1 Nat L1, and pCDNA3BPV1 Mod L1.

Cell culture and DNA transfection. KCs were isolated from newborn mouse skin as previously described (51). Isolated KCs were grown as adherent cultures in a freshly prepared medium (365 ml DMEM medium, 2 mM glutamine, 100 U/ml penicillin, 100 U/ml streptomycin, 125 ml Ham's F12 medium, 50 ml fetal bovine serum, 2.5 mg transferrin, 2.5 mg insulin, 4.2 mg cholera toxin, 0.12 mg hydrocortisone, 17 mg adenine, 10 mg gentamicin) for 1 day and then cultured in KC-SFM medium with low calcium (GIBCO) for 7 days to induce cell differentiation. KCs cultured for 1 or 7 days were transfected with PV L1 gene expression constructs (pCDNA3 Nat HPV6b L1, pCDNA3 Mod HPV6b L1, pCDNA3 Nat BPV1 L1, and pCDNA3 Mod BPV1 L1) using Lipofectamine (Invitrogen) according to the manufacturer's protocol. After transfection, DNA-transfected KCs continued to grow in KC-SFM medium for 42 h before collection for RNA and protein preparation.

RNA Northern blot analysis. Total RNA was extracted from L1 DNA-transfected KCs using a NucleoSpin RNAII Kit (Mackery-Nagel). For cytoplasmic RNA purification, buffer RLN (50 mM Tris [pH 8.0], 140 mM NaCl, 1.5 mM MgCl2, 0.5% Nonidet P-40) was directly added to monolayer cells, and cells were lysed at 4°C for 5 min. After the nuclei were removed by centrifugation, cytoplasmic RNAs were purified by a QIAGEN kit (QIAGEN). Following DNase I treatment, 10- or 15-µg RNA samples were electrophoresed in 1.2% denatured agarose gels and blotted onto a Nylon N+ membrane (Amersham). The Northern blots were probed with an equal mixture of 32P-labeled Nat and Mod PV L1 gene probes. To visualize internal controls, the Northern blots were stripped and reprobed with a 32P-labeled glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene probe.

Reverse transcriptase PCR (RT-PCR) and quantitative RT-PCR. A 0.5-µg sample of RNA purified from cultured KCs transfected with different PV L1 gene expression constructs was converted to cDNA using random primers and PowerScript RT (Clontech) according to the manufacturer's protocol. We used 20 ng of cDNA from each RNA sample in a 20-µl RT-PCR mixture using the FastStart DNA Master SYBR Green I kit (Roche) supplemented with 3 mM MgCl2 and Platinum Taq polymerase (Invitrogen). Quantitative RT-PCR was undertaken using the TaqMan system (Applied Biosystems). The efficiency of amplification for each pair of primers was determined using a standard curve that was generated using serially diluted plasmid DNA. Transcription of each investigated L1 gene, mouse K14, and involucrin was compared to {gamma}-actin (46).

Western blot analysis. DNA-transfected KCs were collected for protein preparation 42 h posttransfection. Cell pellets were resuspended in phosphate-buffered 0.15 M sodium chloride (PBS), pH 7.4, containing 2 mM phenylmethylsulfonyl fluoride and sonicated for 40 s. Fifty-microgram total protein samples were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and blotted onto polyvinylidene difluoride membrane. The blots were first probed by monoclonal antibodies against PV L1 protein and ß-tubulin. Blots were then probed with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin G (IgG; Sigma) and visualized using a chemiluminescence system (Amersham).

Use of the gene gun. Flank and belly skin of BALB/c mice 6 weeks old was shot by particle bombardment with DNA-coated gold beads coated with Nat and Mod human and bovine PV L1 gene plasmids (2 µg DNA per dose) using the helium-powered Helios gene gun delivery system at a pressure setting of 480 lb/in2 based on the expression of a Mod gfp gene (Bio-Rad Laboratories, Richmond, CA). Eight mice were used for the gene gun delivery of each L1 plasmid DNA. Skin was collected 42 h after particle bombardment, fixed using 10% neutral buffered formalin, and embedded in paraffin for sectioning.

Immunofluorescence labeling of L1, K14, and involucrin protein in vitro and in vivo. KCs were grown on eight-well chamber slides, transfected with the different plasmids, fixed, and permeabilized with 85% ethanol 42 h posttransfection. Fixed KCs were blocked with 5% skim milk-PBS and probed with monoclonal antibody against PV1 L1 protein (67), followed by Cy3-conjugated anti-mouse IgG (Sigma). L1-labeled KCs were further blocked with 5% skim milk-PBS and probed with fluorescein isothiocyanate-conjugated monoclonal antibody against keratin 14 (K14; Covance). Fixed KCs were probed with antibody against involucrin protein (Covance), followed by fluorescein isothiocyanate-conjugated secondary antibody. Nuclei were counterstained by 4',6'-diamidino-2-phenylindole (DAPI). KCs were examined by immunofluorescence microscopy. Fixed skin section samples were similarly stained for PV L1 protein.

Isolation of differentiated and undifferentiated KCs from mouse and cow skin. Differentiated and undifferentiated KCs were isolated from mouse and cow skin as previously described (48).

Preparation of aa-tRNAs. Total tRNAs were extracted and purified from undifferentiated and differentiated KCs using a QIAGEN kit (QIAGEN). aa-tRNAs were produced as previously described (69).

High-pressure liquid chromatography (HPLC) analysis of tRNAs. HPLC analysis was carried out on a Waters liquid chromatography system equipped with an LC-100 column oven, a spectrophotometric detector with a 254-nm filter, and a Waters Chromatopac (Waters). tRNA (40 to 60 µg) treated with 20% trifluoroacetic acid (TFA) and formic acid for 1 h was injected into a Luna 5-µm C18 column prefitted with a 7-mm guard column (Phenomene). Elution was achieved using a 0% to 30% linear gradient of 1 M ammonium acetate-0.1% TFA, pH 3.2, and 50% acetonitrile-0.025 M potassium orthophosphate-0.1% TFA, pH 5.0, over 120 min. The chromatographic run was carried out at 37°C at a flow rate of 0.4 ml/min.

tRNA dot blot hybridization. One hundred nanograms of tRNA, after denaturation in 1 M deionized glyoxal-20 mM NaPO4 (pH 7.0) at 50°C for 1 h, was applied to a Nytran blot using a 24-well slot blot apparatus. The blot, after incubation in 20 mM Tris-HCl (pH 8.0) at 100°C for about 10 min, was then air dried and cross linked by 254-nm irradiation. The cross-linked blot was prehybridized with hybridization buffer containing 6x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 10x Denhardt solution, 0.2% SDS, and 1 mM EDTA at 37°C for at least 4 h. The blot was then hybridized with DNA oligonucleotide probes complementary to tRNAMet(initiator), tRNAAla(CGA), tRNAArg(CGA), tRNAAsp(GAC), tRNAAsn(AAC), and tRNAAsn(AAG) in 4x SET buffer (1x SET is 0.15 M NaCl, 0.03 M Tris HCl, and 2 mM Na2EDTA, pH 8.0) at 37°C overnight. The DNA oligonucleotide probe complementary to mammalian tRNAMet(initiator) is 5'-TAGCAGAGGATGGTTTC-3', and that complementary to tRNAAsn(AAT) is 5'-CGTCCCTGGGTGGGCTC-3'. DNA oligonucleotide probes complementary to mouse and bovine tRNAAla(GCA) are 5'-TAAGGACTGTAAGACTT-3' (mouse) and 5'-TAAGGATTGCAAGACTA-3' (bovine), those complementary to mouse and bovine tRNAArg(CGA) are 5'-CGAGCCAGCCAGGAGTC-3' (mouse) and 5'-TTGGTAATTATGAATTA-3' (bovine), those complementary to mouse and bovine tRNAAsp(GAC) are 5'-TAAGATATATAGATTAT-3' (mouse) and 5'-TGAGGTGTACAGGACTT-3' (bovine), and those complementary to mouse and bovine tRNAAsn(AAC) are 5'-CTAGATTGGCAGGAATT-3' (mouse) and 5'-CTAGACTGGTGGGCTCC-3' (bovine). The DNA oligomers were labeled with T4 polynucleotide kinase (Amersham) and [{gamma}-32P]ATP (3,000 Ci/mmol; Amersham) at the first 5' end. Specific activities of 108 to 109 cpm/µg were generally reached. Approximately 107 cpm of oligomers was used per blot in hybridization reactions. Blots were washed with 1x SET buffer at 37°C and autoradiographed.

Cell-free in vitro translation assay. For in vitro translation, L1 plasmid (1 µg) was added to 20 µCi of [35S]methionine (Amersham), and 40 µl of T7 DNA polymerase-coupled rabbit reticulocyte lysates (Promega), with or without additional aa-tRNAs as indicated. Translation was performed at 30°C and stopped by adding SDS loading buffer. The L1 proteins were separated by SDS-polyacrylamide gel electrophoresis on a 10% gel and blotted onto polyvinylidene difluoride membrane. The blots were imaged by phosphor screen and quantified by densitometric analysis using the ImageQuant program (Molecular Dynamics).

Codon usage analysis of mouse K14, involucrin, and HPV6 L1 genes. DNA-coding sequences for the K14, involucrin, and HPV6 L1 genes were downloaded from the website of the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/mapview/). The codon usage pattern of the three genes was analyzed by a computer program [CodonFrequency(GCG)] at the website of the ANGIS Bioinformatic Forum (http://www.angis.org.au/html/index.html). The frequency of use of 64 codons for each gene was tabulated (available on request).


   RESULTS
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Codon usage determines differentiation-dependent expression of PV L1 genes in KC cultures in vitro. We prepared primary KC cultures from newborn mouse skin and induced differentiation in vitro. Progressive differentiation of the KCs cultured from day 1 to day 7 was confirmed by microscopic appearance, increased Papanicolaou staining for cytokeratins (43), progressive loss of expression of the basal cell keratin K14 (4, 19, 44), terminally differentiation-dependent expression of involucrin (13, 40), and progressive nuclear condensation (Fig. 1A to F). KCs cultured for 1 or 7 days were transiently transfected with the Nat L1 gene of two PVs (HPV6b, BPV1). After 42 h, L1 mRNA was detected in undifferentiated and differentiated KCs, whereas L1 protein was detected only in cultures of differentiated KCs, as determined by immunofluorescence in situ (Fig. 2A and B) or by immunoblotting of cell extracts (Fig. 2C and D). In further experiments, KCs were transfected after a period of 0 to 7 days in culture, during which time progressive KC differentiation was observed. Expression of L1 protein over the 24 h following transfection increased progressively, when cells were allowed to differentiate more prior to transfection (data not shown). These results confirm that for adherent primary KC cultures, as for suspension cultures (49), expression of PV L1 proteins is differentiation dependent.



View larger version (29K):
[in this window]
[in a new window]
  		FIG. 1. Cultured primary KCs differentiate between day 1 (D1) and day 7 (D7) in vitro. Primary in vitro murine KC cultures were exposed to differentiation medium for 7 days. At days 1 and 7, cells were compared for morphology (A) and for cellular differentiation using Papanicolaou stain (B). Expression of K14, an early differentiation marker detected by indirect immunofluorescence, is shown in green (C), and nuclei from the same field were counterstained blue with DAPI (D). Expression of involucrin, a late differentiation marker detected by indirect immunofluorescence, is shown in green (E), and nuclei from the same field were counterstained blue with DAPI (F).

 


View larger version (42K):
[in this window]
[in a new window]
  		FIG. 2. Codon usage determines the timing of expression of the PV L1 capsid gene as KCs differentiate in vitro. KCs cultured for 1 day (D1) or 7 days (D7) were transfected with an expression construct for a Nat or Mod PV L1 capsid gene as indicated. (A and B) At 42 h after transfection, cells were stained by indirect immunofluorescence (A, 1 day; B, 7 days) for human PV L1 protein (red) and for K14 (green) and nuclei counterstained with DAPI (blue). Overlaid panels combine all three images. Magnification of all images, x400. (C and D) For 1- and 7-day cultured KCs similarly transfected with Nat or Mod human (C) and bovine (D) PV L1 genes, L1 mRNA was assessed by RT-PCR using cellular actin (Act) as an internal standard and by quantitative RT-PCR. Results are shown as the mean (± the standard error of the mean) of four individual assays from two independent experiments. L1 protein levels were assessed by immunoblotting using cellular tubulin (Tub) as an internal standard.

 
PV L1 and L2 genes demonstrate a strong bias toward the usage of 18 codons with T at the third position that mammalian genes rarely include (68, 69). To test the hypothesis that codon usage bias might determine the differentiation-dependent translation of the L1 genes in cultured KCs, we examined the expression of two heavily codon-substituted L1 genes in differentiating KCs, as these genes, encoding unmodified L1 proteins, have been shown to be expressed well in a wide range of cells in vitro (24, 41, 69). The Mod L1 genes were each transcribed in both undifferentiated and differentiated KCs (Fig. 2C and D); L1 protein, however, was expressed in D1-transfected (undifferentiated) KCs but not in in vitro D7-transfected (differentiated) KCs (Fig. 2A and B). Thus, these data suggest that the synonymous codon use of the Nat L1 genes is adapted to expression of their protein products in KCs according to the differentiation stage of the cells.

Codon usage determines how L1 protein expression is targeted to different sites of the mouse skin in vivo. To confirm our in vitro findings in vivo, expression of the Nat and Mod L1 genes in mouse skin was investigated following gene delivery by DNA particle bombardment. A gfp gene encoding green fluorescent protein modified for expression in mammalian cells, and known to be expressed well in all layers of skin, was used as a control for DNA particle bombardment (Fig. 3B). Using the same helium pressure setting, both Nat and Mod L1 genes were delivered to mouse skin. RNA in situ hybridization revealed that the L1 genes, whether Nat or Mod, were each transcribed in both basal and superficial epithelial cells (data not shown). However, in keeping with the in vitro findings, L1 protein was expressed from the Nat sequence L1 genes only in the most superficial epithelial cells (Fig. 3C and D), including superficial differentiated KCs in deeper hair follicles (Fig. 3C and D). In contrast, the Mod L1 genes were expressed more extensively throughout the epidermis and dermis, except for the most superficial KC layers (Fig. 3E and F). Thus, the results indicate that the codon usage of the PV L1 gene determines the site of expression of L1 protein within the mouse epidermis in vivo.



View larger version (72K):
[in this window]
[in a new window]
  		FIG. 3. Codon usage determines the spatial expression of the PV L1 capsid gene in skin in vivo. Expression constructs for Nat (C and D) or Mod (E and F) HPV6 and BPV1 L1 genes or for humanized (hm) green fluorescent protein (B) were delivered on gold beads (2 µg/dose) to the flank skin of BALB/c mice using a biolistic delivery system (Helios; Bio-Rad Laboratories, Richmond, CA). Control skin (A) was left untreated. After 42 h, skin was fixed in 10% neutral buffered formalin, sectioned, and stained as indicated for L1 protein by indirect immunofluorescence (red) or for nuclei using DAPI (blue). Epidermis (E), dermis (D), and hair follicles (H) of the skin section are indicated in panel A. Magnification of all sections, x400.

 
Codon modification does not affect the stability of PV L1 mRNA in undifferentiated and differentiated KCs. The above results indicate that the site of expression of L1 protein from either Nat or Mod PV L1 genes is determined by a differentiation-linked process apparently acting at a posttranscriptional level. Regulation of mRNA stability is an important element in the posttranscriptional control of gene expression (37). Accordingly, we examined the stability of the Nat and Mod PV L1 mRNAs in undifferentiated and differentiated KCs. KCs cultured for 1 or 7 days were transiently transfected with the Nat or Mod L1 genes of two PVs (HPV6b, BPV1). At 18 h posttransfection, the KCs, treated with actinomycin D (Act D) to prevent further gene transcription for 0, 2, 5, or 8 h, were harvested for total RNA preparation. L1 mRNA was detected by Northern blot analysis and compared with GAPDH mRNA (Fig. 4A and B, insets). As shown by quantitative RT-PCR (Fig. 2C and D), the steady-state levels of L1 mRNA transcribed from the Mod PV L1 genes were several times higher than the levels expressed from Nat PV L1 genes (Fig. 4A and B, insets). The half-lives of both Nat and Mod L1 mRNAs were then calculated as the time period necessary to reduce the amount of L1 mRNA in Act D-treated KCs to 50% of the original L1 mRNA abundance at time point zero (0 h) (Fig. 4A and B). In D1-transfected undifferentiated KCs, the half-lives of the Nat L1 mRNAs were 5.3 ± 0.8 h for HPV6b and 5.2 ± 0.7 h for BPV1, whereas those of the Mod L1 mRNAs were nonsignificantly shorter at 4.7 ± 0.8 h for HPV6b and 4.8 ± 0.8 h for BPV1 (Fig. 4A and B). In D7-transfected differentiated KCs, the half-lives of the Nat L1 mRNAs were 4.3 ± 0.4 h for HPV6b and 4.4 ± 0.6 h for BPV1 and the half-lives of the Mod L1 mRNAs were nonsignificantly longer at 5.0 ± 0.7 h for HPV6b and 4.6 ± 0.4 h for BPV1 (Fig. 4A and B). Thus, codon modification does not alter the stability of PV L1 mRNAs in cultured KCs sufficiently to explain the observed differences in steady-state L1 protein levels.



View larger version (46K):
[in this window]
[in a new window]
  		FIG. 4. Half-lives of L1 mRNAs transcribed from the Nat or Mod PV L1 capsid gene in cultured KCs. KCs cultured for 1 day (D1) or 7 days (D7) were transfected with an expression construct for a Nat or Mod PV L1 capsid gene as indicated. At 18 h after transfection, cells were treated with Act D (500 ng/ml) and total RNAs were harvested at 0, 2, 5, and 8 h for Northern blot hybridization and mRNA stability analysis. Fifteen micrograms of total RNA from Nat PV L1-transfected KCs (10 µg of total RNA from Mod PV L1-transfected KCs) treated with DNase I was electrophoresed on a 1.2% denatured agarose gel and blotted onto a nylon membrane. The Northern blots were probed with an equal mixture of 32P-labeled Nat and Mod PV L1 gene probes. To visualize the internal controls, the Northern blots were stripped and reprobed with a 32P-labeled GAPDH gene probe. (A, B) Densitometric quantification of Nat and Mod HPV6b and BPV1 L1 mRNA levels following normalization to GAPDH. The half-lives of Nat and Mod HPV6b and BPV1 L1 mRNAs, calculated as the times required for a given transcript to decrease to 50% of its initial abundance (horizontal dotted lines), are shown in parentheses. The data shown are the means (± the standard error of the mean) of four individual blotting assays from two independent experiments. Insets are representative Northern blot analyses (n = 4) of Nat and Mod HPV6b and BPV1 L1 and GAPDH RNA expression in day 1 and day 7 L1-transfected KCs. Statistical analysis of the results from the experiments was conducted using one-way analysis of variance. No significant difference between Nat and Mod L1 half-lives was obtained (P > 0.05).

 
As the transport of mRNAs to the cytoplasm is delayed until RNA splicing is completed (30, 56), we repeated, using cytoplasmic mRNA, the L1 mRNA half-life studies in differentiated KCs and quantitated mRNA by Northern blotting hybridization (Fig. 5A and B) and quantitative RT-PCR (data not shown). L1 mRNAs, whether transcribed from Nat or Mod PV L1 genes, were efficiently exported from the nucleus to the cytoplasm of KCs (Fig. 5A and B). The half-lives of the cytoplasmic Nat L1 mRNAs were 3.9 ± 0.7 h for HPV6b and 5.2 ± 0.7 h for BPV1, whereas those of the Mod L1 mRNAs were nonsignificantly different from the Nat mRNAs at 4.3 ± 0.5 h for HPV6b and 5.5 ± 0.8 h for BPV1 (Fig. 5A and B). Thus, differences in the cytoplasmic pools of mRNA are unlikely to account for the observed differences in L1 production from Nat and Mod L1 genes in differentiated cells.



View larger version (26K):
[in this window]
[in a new window]
  		FIG. 5. Stability of cytoplasmic L1 mRNAs transcribed from the Nat or Mod PV L1 capsid genes in differentiated KCs. KCs cultured for 7 days (D7) were transfected with an expression construct for a Nat or Mod PV L1 capsid gene as indicated. At 18 h after transfection, KCs were treated with Act D (500 ng/ml) and cytoplasmic RNAs were prepared at 0, 2, 5, and 8 h for Northern blot hybridization and mRNA stability analysis. Ten micrograms of cytoplasmic RNA treated with DNase I was electrophoresed on a 1.2% denatured agarose gel and blotted onto a nylon membrane. The Northern blots were probed with an equal mixture of 32P-labeled Nat and Mod PV L1 gene probes. As internal controls, the Northern blots were stripped and reprobed with a 32P-labeled GAPDH gene probe. (A and B, left) Representative Northern blot analysis (n = 2) of Nat and Mod HPV6b and BPV1 cytoplasmic L1 and GAPDH RNA expression in day 7 L1-transfected KCs. (Right) Half-lives of Nat and Mod HPV6b and BPV1 cytoplasmic L1 mRNAs assessed by densitometric quantification following normalization to GAPDH. Data shown in parentheses are the means (± the standard error of the mean) of duplicate blot assays.

 
tRNA profiles differ between undifferentiated and differentiated KCs. To explain the observation that codon modification of the L1 gene could alter the expression of L1 protein in differentiating KCs without altering mRNA levels or stability, we hypothesized that observed translational differences likely reflected different availability of aa-tRNAs between differentiated and undifferentiated KCs. We therefore extracted tRNAs from murine and bovine epidermal cells, sorted by size and buoyant density into smaller undifferentiated cells and larger differentiated cells, and confirmed the differentiation state of the cells by K14 and involucrin staining and morphology (Fig. 6). tRNA species were then profiled for each cell population by HPLC separation (Fig. 6). tRNA profiles of murine and bovine epithelial cells were similar (Fig. 6A, B, C, and D), and the profiles of differentiated cells were in each case distinct from undifferentiated cells (Fig. 6), showing, as for studies with tumor cells and cells of parent tissues (34), that cell differentiation can alter the aa-tRNA pool. As no validated technology is available for identification and quantitation of individual tRNA species in cells by HPLC or otherwise, we arbitrarily chose several tRNA oligonucleotide probes complementary to specific regions of six tRNAs, tRNAMet(Initiator), tRNAAla(CGA), tRNAArg(CGA), tRNAAsp(GAC), tRNAAsn(AAC), and tRNAAsn(AAT), to examine whether reactivity with these probes differed between undifferentiated and differentiated KCs. Reactivity with the tRNAMet(Initiator) probe was similar between undifferentiated and differentiated KCs (Fig. 6E). Reactivity with the probes corresponding to four tRNAs, tRNAAla(GCA), tRNAArg(CGA), tRNAAsp(GAC), and tRNAAsn(AAC), was consistently stronger in undifferentiated KCs than in differentiated KCs (Fig. 6E), and reactivity with tRNAAsn(AAT) was consistently weaker (Fig. 6E). Thus, HPLC tRNA profile differences between differentiated and undifferentiated KCs are reflected in differences in hybridization-determined tRNA reactivity.



View larger version (54K):
[in this window]
[in a new window]
  		FIG. 6. tRNA profiles and dot blot-examined tRNA species differ between differentiated and undifferentiated KCs. (A to D) Total tRNA was extracted, using a kit (QIAGEN), from single-cell suspensions derived by collagenase and trypsin digestion from murine flank skin (A and B) and bovine ear skin (C and D) and separated into basal (undifferentiated) cells (A and C, insets) and squamous (differentiated) cells (B and D, insets) by density flotation on a discontinuous 30% to 70% Percoll gradient. The differentiation state of the isolated undifferentiated and differentiated cells was confirmed by K14 and involucrin (Invol.) staining (A and B). Nucl., nucleus. Extracted tRNAs were dissolved in water, and HPLC retention profiles were determined using a Luna 5-µm C18 column (Phenomene) and a linear elution gradient of acetonitrile up to 30% over 2 h at 37°C. (E) tRNA dot blot hybridization of tRNA samples from undifferentiated (Undi.) and differentiated (Diff.) KCs. The details are described in Materials and Methods.

 
Translation of Nat PV L1 genes is preferentially enhanced by aa-tRNAs from differentiated KCs. We have previously shown that altering the available pool of aa-tRNAs alters the expression of a Nat L1 gene in cell-free in vitro translational studies (69). To show directly that the aa-tRNA populations of differentiated KCs favor translation of Nat L1, we firstly confirmed that translation of L1 protein from Nat L1 genes was much slower than that from the Mod L1 genes (Fig. 7A) using a rabbit reticulocyte lysate cell-free in vitro translation system that has fixed pools of aa-tRNAs and amino acids. We then examined whether addition of aa-tRNAs from undifferentiated or differentiated murine KCs could enhance the translation of the Nat and Mod L1 genes (Fig. 7B). Introduction of exogenous tRNAs from differentiated KCs but not undifferentiated KCs enhanced the translation of Nat L1 genes in a dose-dependent manner, with optimum efficiency at 10–7 M (Fig. 7B). aa-tRNA from differentiated KCs at 10–7 M significantly enhanced the translation of L1 3.1-fold ± 0.7-fold (standard error of the mean) for HPV6b and 2.5-fold ± 0.9-fold for BPV1 at 12 min, whereas 10–7 M aa-tRNA from undifferentiated KCs gave less-significant enhancement (1.7-fold ± 0.5-fold increase for HPV6b and 1.4-fold ± 0.3-fold for BPV) compared to control reaction mixtures without added aa-tRNAs (Fig. 7C). Supplementation of the aa-tRNAs from undifferentiated or differentiated murine KCs had no significant effect on the translation of the Mod L1 genes (data not shown). We thus conclude that aa-tRNA availability changes in KCs with cellular differentiation, and the aa-tRNA pool in differentiated KCs enables more-efficient translation of the "rarely used" codons in the Nat L1 gene than the aa-tRNA pool in undifferentiated KCs.



View larger version (57K):
[in this window]
[in a new window]
  		FIG. 7. Translation of PV L1 capsid genes is preferentially enhanced by aa-tRNA from differentiated KCs. L1 genes from HPV6 and BPV1 were translated in a cell-free system using rabbit reticulocyte lysate (in the presence of [35S] methionine. Production of 35S-labeled L1 was assessed by autoradiography of polyacrylamide gel electrophoresis-separated proteins. (A). Production over time of L1 protein from Nat L1 genes (HPV6b and BPV1) is less rapid than from Mod L1 genes. (B). Supplementation of the in vitro translation reaction mixture with aa-tRNA from differentiated (Diff.) or undifferentiated (Undi.) KCs enhances L1 production from Nat L1 genes in a dose-dependent manner from 10–8 to 10–6 M; inhibition of translation is evident at the highest concentrations of aa-tRNA. (C) Addition of aa-tRNAs prepared from differentiated KCs (10–7 M) increased the rate of translation of Nat L1 genes more effectively than aa-tRNAs from undifferentiated KCs over a time course of 8 to 16 min. (D) Means (± the standard error of the mean) of L1 production from three independent experiments quantitated by scanning densitometry of autoradiographs. Statistical analysis of the results from individual time points from these experiments was conducted using analysis of variance (P < 0.05 and P < 0.01 compared with no addition of aa-tRNAs as shown).

 
Codon usage may also regulate the expression of some mammalian proteins associated with KC differentiation. To investigate whether differentiation-dependent expression of mammalian proteins might in part be determined by their codon composition and by tRNA abundance differences associated with cellular differentiation, we examined the expression of the K14 and involucrin genes in day 1 and day 7 cultured KCs by RT-PCR and immunoblotting (Fig. 8A and B). As shown by RT-PCR, the mRNA transcripts of both K14 and involucrin were at a steady-state level in day 1 and day 7 cultured KCs (Fig. 8A and B). However, immunoblotting of day 7 cultured KCs revealed that expression of K14 protein was down-regulated, in contrast to the significantly up-regulated expression of involucrin (Fig. 8A and B), consistent with the observations of immunofluorescence in situ (Fig. 1C and E). We examined the codon usage of mouse K14 and involucrin genes in comparison with the HPV6 Nat L1 gene by tabulating the percentage of codons with G/C or A/T at the third position for each gene (Table 1). The K14 gene has a significantly greater usage of third-position G/C residues than the involucrin gene (Table 1), while the HPV6 L1 Nat gene has the least use of third-position G/C residues (Table 1). The involucrin protein includes several glutamine residues, 102 of which are encoded by a Glu(GAG) codon. If these glutamine residues are excluded, the involucrin gene has as high a percentage of AT-ending codons (56/100) as the HPV6 L1 Nat gene. In view of this finding and tRNA dot blot hybridization data showing that undifferentiated KCs are apparently rich in tRNA-Asp(GAC) and tRNA-Asn(AAC) (Fig. 6E), we compared the codon usage of the three genes for the amino acids Asp and Asn (Table 2). The K14 gene, in contrast to the involucrin and HPV6 Nat L1 genes, has a high percentage of GAC codons for amino acid Asp, supporting our finding that tRNA-Asp(GAC) abundance correlates with high-level expression of K14 protein in undifferentiated KCs (Fig. 6E and 8A). Thus, at least two mammalian genes differentially expressed between differentiated and undifferentiated KCs may use a subset of favored codons matching the abundance of the isoacceptor tRNAs to regulate expression of the corresponding proteins during KC differentiation.



View larger version (45K):
[in this window]
[in a new window]
  		FIG. 8. mRNA translation efficiency of KC structural genes differs with KC differentiation. KCs cultured for 1 day (D1) or 7 days (D7) were harvested for RNA and protein preparation. K14 and involucrin (Invol) mRNAs were assessed by RT-PCR and proteins by immunoblotting using actin as an internal standard. The results are representative of two independent experiments (n = 4) in day 1 and day 7 cultured KCs.

 

View this table:
[in this window]
[in a new window]
  		TABLE 1. Comparison of codon usage between K14, involucrin, and HPV6 L1a

 

View this table:
[in this window]
[in a new window]
  		TABLE 2. Usage of codons corresponding to abundant aa-tRNAs in KCsa

 

   DISCUSSION
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
We demonstrate here that KCs differentiated in vitro and displaying KC differentiation markers produce PV L1 protein more efficiently from the L1 gene than undifferentiated KCs. Further, mRNA quantitation demonstrates that the difference in L1 protein expression between differentiated and undifferentiated KCs is largely determined posttranscriptionally. Generalized substitution, within the L1 gene, of isoencoding codons with a G or a C at redundant positions within the codon triplet enhances expression of L1 protein in undifferentiated KCs and impairs expression in differentiated KCs. In vivo observations in epidermis transduced with Nat or Mod L1 are consistent with our in vitro data and with the specific expression of PV L1 protein in differentiated KCs observed in the course of natural PV infection.

Several posttranscriptional mechanisms for regulation of expression of broad subsets of genes on cell differentiation are recognized, including changes in the assembly of the eukaryotic translation-initiation factor complex and expression of specific RNA binding proteins targeting cis-regulatory sequences associated with genes expressed on differentiation (reviewed by Calkhoven et al. [6]) (47). However, we show here that provision of aa-tRNAs from differentiated KCs but not undifferentiated KCs enhances the translational efficiency of the Nat L1 gene in a cell-free system and has no effect on translation using the same expression vector of a Mod L1 gene which, as a result of codon modification, is well expressed in undifferentiated KCs. This observation is difficult to explain as a consequence of the generally active posttranslational mechanisms for regulation of gene expression discussed by Calkhoven et al. as associated with cell differentiation and more strongly supports a hypothesis that aa-tRNA changes associated with cell differentiation may, in association with selective codon usage, regulate the translation of some genes within a cell lineage.

Replacement of less-preferred codons within a prokaryotic gene with synonyms more commonly observed in mammalian genes can greatly increase gene expression in eukaryotic cells, with improvement in translational efficiency attributed to correction of a mismatch between eukaryotic cell tRNA pools and preferred prokaryotic gene codon bias (26, 39, 61, 70). Plotkin et al., using in silico analysis of codon usage in eukaryotic genes differentially expressed in uterus and testis tissues and in brain and liver tissues (47), have recently hypothesized that posttranscriptional controls based on gene codon usage may also play an important role in the regulation of tissue-specific gene expression in mammals. Further, impaired viral protein expression in mammalian host cells, attributed to codon usage divergence of viral and human genes, is observed for the latent genes of Epstein-Barr virus (31), the env gene of human immunodeficiency virus type 1 (25), and the E7 (9), L1, and L2 genes (69) of PV. Thus, the codon composition of PV L1 genes might be expected to influence L1 expression according to the availability of aa-tRNA within the cell. The correlation observed in the present study between differences in aa-tRNA species and differential L1 gene expression for differentiated and undifferentiated KCs may have broad significance for selective gene expression within multicellular eukaryotic organisms. In Escherichia coli and in yeasts, highly expressed genes use a subset of codons corresponding to the highly expressed isoacceptor tRNAs (3, 23) and the synthesis of a number of colicins is linked to the difference in tRNA availability for the various codons used by the relevant genes (60). More generally, the pool of available aa-tRNAs is held to be rate limiting for accuracy and efficiency of gene translation (18, 27, 28, 59, 66). However, in multicellular eukaryotes, there are very few experimental data on tRNA abundance (15), though a relationship is reported between tRNA abundance and codon usage in Drosophila (45). Reliable methods for accurately measuring the range of specific tRNAs in eukaryotic cells and for distinguishing among free tRNA, free aa-tRNA, and ribosome-associated aa-tRNA have not yet been developed. Our tRNA dot blot hybridization data for tRNA abundance are limited to a small subset of tRNAs and cannot distinguish tRNA from aa-tRNA. These data show higher total tRNAAsp(GAC) and tRNAAsn(AAC) levels in undifferentiated KCs than in differentiated KCs. The Asp(GAT) and Asn(AAT) codons, which are abundant in natural L1 genes (68, 69), are substituted in the Mod L1 genes with Asp(GAC) and Asn(AAC). Better translation of the Mod L1 genes in undifferentiated KCs is thus consistent with the tRNA abundance data and suggests that the Asp(GAT) and Asn(AAT) aa-tRNAs may be rate limiting for expression of L1 in differentiated KCs. Further correlations of specific aa-tRNA abundance with gene translation efficacy await the development of better methods for measuring the complete set of aa-tRNAs.

Alternate methods for regulation of PV L1 expression in differentiating epithelium have been proposed. The PV late promoter, from which the L1 gene is naturally expressed, is more active in differentiated than undifferentiated epithelium (2, 33), though studies with raft cultures suggest that late gene translation in differentiated cells requires the viral genome to be extrachromosomal (21, 33), suggesting a more complex model of regulation involving additional posttranscriptional controls. Regulation of mRNA stability or decay is an important control point for gene expression and is mediated by nucleotide sequence elements, specific cellular protein factors, and endoribonucleases (63). Duan and Antezana (14) reported that synonymous codon substitution in the coding region of gene DRD2 can affect mRNA stability. Many studies have described determinants of mRNA stability in the coding region in a range of genes (7, 8, 12, 58, 65), including the HPV16 L2 gene (55). It therefore seems important to consider the extent to which mRNA stability contributes to differentiation-dependent differences in PV L1 gene expression observed in KCs. HPV1 mRNAs containing an AU-rich noncoding sequence which, in sense orientation, reduces their half-life: mRNA destabilization requires multiple RNA binding proteins (54). Described mRNA stability elements in PV L1 and L2 genes are mainly located in the PV-encoded 5' and 3' untranslated regions containing AU-rich sequences (32, 54, 62), and these would not be expected in our engineered L1 expression constructs. Further, the effects of stability sequences on mRNA stability, at least for BPV1 L1, appear to be smaller in magnitude (22) than our observed difference in L1 translation efficiency between differentiated and undifferentiated KCs, suggesting that even if our L1 constructs encode the RNA sequences that bind destabilizing RNA binding proteins, and these proteins are only present in undifferentiated KCs, they are still insufficient to explain our observed difference in L1 expression with KC differentiation. cis-acting regulatory sequences have been described in the HPV16 L1 gene 3' coding sequence (11) but have not been shown to be effective in epithelium or, more significantly, to be selectively lost in KCs on differentiation, as would be required to explain specific expression of PV L1 protein in differentiated KCs. Rather, the present study shows that Nat HPV16 L1 mRNAs are of similar stability in differentiated and undifferentiated KCs, as are mRNAs from Mod L1. Thus, it is unlikely that L1 mRNA stability is a major determinant of the differentiation-determined selective posttranscriptional block to L1 capsid protein synthesis we observed for Nat and Mod PV L1 transcripts in cultured KCs. Further, the half-life of the less efficiently translated Nat and Mod PV L1 transcripts in KCs appears paradoxically to be somewhat longer than for the more efficiently translated L1 mRNAs. The stability of some mRNAs is affected by translation (52, 57, 64). Based on the present observations, the stability of PV L1 transcripts, rather than being a major determinant of efficient L1 translation, may be regulated in part by L1 mRNA translation efficiency, determined in KCs by a differentiation-determined match between L1 codon usage and the availability of aa-tRNAs.

In the present study, HPLC analysis has revealed that tRNA profiles of differentiated cells were in each case distinct from undifferentiated cells in both murine and bovine epithelium. What mechanism may drive the difference in tRNA profiles between undifferentiated and differentiated KCs? Epidermal KCs are highly specialized epithelial cells designed to perform a very specific function, separation of the organism from its environment. During the KC differentiation process, numerous genes are turned on and off at specific stages (16, 17). One possibility is therefore that the observed changes in the available aa-tRNA pool between differentiated KCs and undifferentiated KCs reflects regulated tRNA production or aminoacylation of tRNAs with differentiation. Alternatively, the pool of free aa-tRNAs might be determined by the extent to which particular aa-tRNAs are needed by the cell for protein production, as the majority of charged tRNAs are associated with nascent protein production in the ribosome in metabolically active cells (29). Further elucidation of the mechanism varying the pool of aa-tRNA with epithelial differentiation must await better methods of quantitating specific aa-tRNA species change in real time.


   ACKNOWLEDGMENTS
 
This work was funded in part by the Queensland Cancer Fund (Q68) and by a National Health and Medical Research Council of Australia Industry research fellowship (301256) to K.N.Z.

We thank Kelly Minto for assistance with the animal work.


   FOOTNOTES
 
* Corresponding author. Mailing address: Centre for Immunology and Cancer Research, The University of Queensland, Research Extension, Building 1, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland 4102, Australia. Phone: 07 3240 5282. Fax: 07 3240 5946. E-mail for Kong-Nan Zhao: knzhao{at}cicr.uq.edu.au. E-mail for Ian H. Frazar: ifrazar{at}cicr.uq.edu.au. Back


   REFERENCES
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
1. Aho, S., M. Buisson, T. Pajunen, Y. W. Ryoo, J. F. Giot, H. Gruffat, A. Sergeant, and J. Uitto. 2000. Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors. J. Cell Biol. 148:1165-1176.[Abstract/Free Full Text]

2. Barksdale, S. K., and C. C. Baker. 1993. Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters. J. Virol. 67:5605-5616.[Abstract/Free Full Text]

3. Bennetzen, J. L., and B. D. Hall. 1982. Codon selection in yeast. J. Biol. Chem. 257:3026-3031.[Abstract/Free Full Text]

4. Bowden, P. E., C. D. Woodworth, J. Doniger, and J. A. DiPaolo. 1992. Down-regulation of keratin 14 gene expression after v-Ha-ras transfection of human papillomavirus-immortalized human cervical epithelial cells. Cancer Res. 52:5865-5871.[Abstract/Free Full Text]

5. Brown, D. R., L. Fan, J. Jones, and J. Bryan. 1994. Colocalization of human papillomavirus type 11 E1E4 and L1 proteins in human foreskin implants grown in athymic mice. Virology 201:46-54.[CrossRef][Medline]

6. Calkhoven, C. F., C. Muller, and A. Leutz. 2002. Translational control of gene expression and disease. Trends Mol. Med. 8:577-583.[CrossRef][Medline]

7. Carlini, D. B., Y. Chen, and W. Stephan. 2001. The relationship between third-codon position nucleotide content, codon bias, mRNA secondary structure and gene expression in the drosophilid alcohol dehydrogenase genes Adh and Adhr. Genetics 159:623-633.[Abstract/Free Full Text]

8. Chiba, Y., M. Ishikawa, F. Kijima, R. H. Tyson, J. Kim, A. Yamamoto, E. Nambara, T. Leustek, R. M. Wallsgrove, and S. Naito. 1999. Evidence for autoregulation of cystathionine gamma-synthase mRNA stability in Arabidopsis. Science 286:1371-1374.[Abstract/Free Full Text]

9. Cid-Arregui, A., V. Juarez, and H. zur Hausen. 2003. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J. Virol. 77:4928-4937.[Abstract/Free Full Text]

10. Collier, B., L. Goobar-Larsson, M. Sokolowski, and S. Schwartz. 1998. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273:22648-22656.[Abstract/Free Full Text]

11. Collier, B., D. Oberg, X. Zhao, and S. Schwartz. 2002. Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J. Virol. 76:2739-2752.[Abstract/Free Full Text]

12. Dibbens, J. A., D. L. Miller, A. Damert, W. Risau, M. A. Vadas, and G. J. Goodall. 1999. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol. Biol. Cell 10:907-919.[Abstract/Free Full Text]

13. Dover, R., and F. M. Watt. 1987. Measurement of the rate of epidermal terminal differentiation: expression of involucrin by S-phase keratinocytes in culture and in psoriatic plaques. J. Investig. Dermatol. 89:349-352.[CrossRef][Medline]

14. Duan, J., and M. A. Antezana. 2003. Mammalian mutation pressure, synonymous codon choice, and mRNA degradation. J. Mol. Evol. 57:694-701.[CrossRef][Medline]

15. Duret, L. 2000. tRNA gene number and codon usage in the C. elegans genome are co-adapted for optimal translation of highly expressed genes. Trends Genet. 16:287-289.[CrossRef][Medline]

16. Eckert, R. L., and J. F. Welter. 1996. Transcription factor regulation of epidermal keratinocyte gene expression. Mol. Biol. Rep. 23:59-70.[CrossRef][Medline]

17. Eckert, R. L., J. F. Crish, E. B. Banks, and J. F. Welter. 1997. The epidermis: genes on-genes off. J. Investig. Dermatol. 109:501-509.[CrossRef][Medline]

18. Elf, J., D. Nilsson, T. Tenson, and M. Ehrenberg. 2003. Selective charging of tRNA isoacceptors explains patterns of codon usage. Science 300:1718-1722.[Abstract/Free Full Text]

19. Faus, I., H. J. Hsu, and E. Fuchs. 1994. Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol. Cell. Biol. 14:3263-3275.[Abstract/Free Full Text]

20. Frattini, M. G., H. B. Lim, and L. A. Laimins. 1996. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc. Natl. Acad. Sci. USA 93:3062-3067.[Abstract/Free Full Text]

21. Frattini, M. G., H. B. Lim, J. Doorbar, and L. A. Laimins. 1997. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates. J. Virol. 71:7068-7072.[Abstract]

22. Furth, P. A., and C. C. Baker. 1991. An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels. J. Virol. 65:5806-5812.[Abstract/Free Full Text]

23. Gouy, M., and C. Gautier. 1982. Codon usage in bacteria: correlation with gene expressivity. Nucleic Acids Res. 10:7055-7074.[Abstract/Free Full Text]

24. Gu, W., M. Li, W. M. Zhao, N. X. Fang, S. Bu, I. H. Frazer, and K. N. Zhao. 2004. tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes. Nucleic Acids Res. 32:4448-4461.[Abstract/Free Full Text]

25. Haas, J., E. C. Park, and B. Seed. 1996. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6:315-324.[CrossRef][Medline]

26. Heim, R., A. B. Cubitt, and R. Y. Tsien. 1995. Improved green fluorescence. Nature 373:663-664.[Medline]

27. Hopper, A. K., and E. M. Phizicky. 2003. tRNA transfers to the limelight. Genes Dev. 17:162-180.[Free Full Text]

28. Ibba, M., H. D. Becker, C. Stathopoulos, D. L. Tumbula, and D. Soll. 2000. The adaptor hypothesis revisited. Trends Biochem. Sci. 25:311-316.[CrossRef][Medline]

29. Janzen, D. M., and A. P. Geballe. 2004. The effect of eukaryotic release factor depletion on translation termination in human cell lines. Nucleic Acids Res. 32:4491-4502.[Abstract/Free Full Text]

30. Jimenez-Garcia, L. F., and D. L. Spector. 1993. In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell 73:47-59.[CrossRef][Medline]

31. Karlin, S., B. E. Blaisdell, and G. A. Schachtel. 1990. Contrasts in codon usage of latent versus productive genes of Epstein-Barr virus: data and hypotheses. J. Virol. 64:4264-4273.[Abstract/Free Full Text]

32. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1991. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65:2093-2097.[Abstract/Free Full Text]

33. Klumpp, D. J., and L. A. Laimins. 1999. Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1. Virology 257:239-246.[CrossRef][Medline]

34. Kuchino, Y., and E. Borek. 1978. Tumour-specific phenylalanine tRNA contains two supernumerary methylated bases. Nature 271:126-129.[CrossRef][Medline]

35. Leask, A., M. Rosenberg, R. Vassar, and E. Fuchs. 1990. Regulation of a human epidermal keratin gene: sequences and nuclear factors involved in keratinocyte-specific transcription. Genes Dev. 4:1985-1998.[Abstract/Free Full Text]

36. Leder, C., J. A. Kleinschmidt, C. Wiethe, and M. Muller. 2001. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J. Virol. 75:9201-9209.[Abstract/Free Full Text]

37. Lemm, I., and J. Ross. 2002. Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant. Mol. Cell. Biol. 22:3959-3969.[Abstract/Free Full Text]

38. Levine, M., and R. Tjian. 2003. Transcription regulation and animal diversity. Nature 424:147-151.[CrossRef][Medline]

39. Levy, J. P., R. R. Muldoon, S. Zolotukhin, and C. J. Link, Jr. 1996. Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells. Nat. Biotechnol. 14:610-614.[CrossRef][Medline]

40. Li, E. R., D. M. Owens, P. Djian, and F. M. Watt. 2000. Expression of involucrin in normal, hyperproliferative and neoplastic mouse keratinocytes. Exp. Dermatol. 9:431-438.[CrossRef][Medline]

41. Liu, W. J., K. N. Zhao, F. G. Gao, G. R. Leggatt, G. J. Fernando, and I. H. Frazer. 2001. Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine 20:862-869.[CrossRef][Medline]

42. Liu, W. J., F. Gao, K. N. Zhao, W. Zhao, G. J. Fernando, R. Thomas, and I. H. Frazer. 2002. Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology 301:43-52.[CrossRef][Medline]

43. Mellors, R. C., J. F. Keane, Jr., and G. N. Papanicolaou. 1952. Nucleic acid content of the squamous cancer cell. Science 116:265-269.[Free Full Text]

44. Merritt, A. J., M. Y. Berika, W. Zhai, S. E. Kirk, B. Ji, M. J. Hardman, and D. R. Garrod. 2002. Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation. Mol. Cell. Biol. 22:5846-5858.[Abstract/Free Full Text]

45. Moriyama, E. N., and J. R. Powell. 1997. Codon usage bias and tRNA abundance in Drosophila. J. Mol. Evol. 45:514-523.[CrossRef][Medline]

46. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.[Abstract/Free Full Text]

47. Plotkin, J. B., H. Robins, and A. J. Levine. 2004. Tissue-specific codon usage and the expression of human genes. Proc. Natl. Acad. Sci. USA 101:12588-12591.[Abstract/Free Full Text]

48. Reiners, J. J., Jr., and T. Rupp. 1989. Conversion of xanthine dehydrogenase to xanthine oxidase occurs during keratinocyte differentiation: modulation by 12-O-tetradecanoylphorbol-13-acetate. J. Investig. Dermatol. 93:132-135.[CrossRef][Medline]

49. Ruesch, M. N., F. Stubenrauch, and L. A. Laimins. 1998. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J. Virol. 72:5016-5024.[Abstract/Free Full Text]

50. Sasagawa, T., P. Pushko, G. Steers, S. E. Gschmeissner, M. A. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206:126-135.[CrossRef][Medline]

51. Saunders, N., A. Dicker, C. Popa, S. Jones, and A. Dahler. 1999. Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res. 59:399-404.[Abstract/Free Full Text]

52. Schwartz, D. C., and R. Parker. 1999. Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:5247-5256.[Abstract/Free Full Text]

53. Schwartz, S. 2000. Regulation of human papillomavirus late gene expression. Upsala J. Med. Sci. 105:171-192.[Medline]

54. Sokolowski, M., C. Zhao, W. Tan, and S. Schwartz. 1997. AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors. Oncogene 15:2303-2319.[CrossRef][Medline]

55. Sokolowski, M., W. Tan, M. Jellne, and S. Schwartz. 1998. mRNA instability elements in the human papillomavirus type 16 L2 coding region. J. Virol. 72:1504-1515.[Abstract/Free Full Text]

56. Spector, D. L. 1993. Nuclear organization of pre-mRNA processing. Curr. Opin. Cell Biol. 5:442-447.[CrossRef][Medline]

57. Surosky, R. T., and R. E. Esposito. 1992. Early meiotic transcripts are highly unstable in Saccharomyces cerevisiae. Mol. Cell. Biol. 12:3948-3958.[Abstract/Free Full Text]

58. Tierney, M. J., and R. L. Medcalf. 2001. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs. J. Biol. Chem. 276:13675-13684.[Abstract/Free Full Text]

59. Tumbula, D. L., H. D. Becker, W. Z. Chang, and D. Soll. 2000. Domain-specific recruitment of amide amino acids for protein synthesis. Nature 407:106-110.[CrossRef][Medline]

60. Varenne, S., D. Baty, H. Verheij, D. Shire, and C. Lazdunski. 1989. The maximum rate of gene expression is dependent on the downstream context of unfavourable codons. Biochimie 71:1221-1229.[Medline]

61. Wells, K. D., J. A. Foster, K. Moore, V. G. Pursel, and R. J. Wall. 1999. Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch. Transgenic Res. 8:371-381.[CrossRef][Medline]

62. Wiklund, L., M. Sokolowski, A. Carlsson, M. Rush, and S. Schwartz. 2002. Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3' untranslated region. J. Biol. Chem. 277:40462-40471.[Abstract/Free Full Text]

63. Wilusz, C. J., M. Wormington, and S. W. Peltz. 2001. The cap-to-tail guide to mRNA turnover. Nat. Rev. Mol. Cell. Biol. 2:237-246.[CrossRef][Medline]

64. Wisdom, R., and W. Lee. 1991. The protein-coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:232-243.[Abstract/Free Full Text]

65. Yeilding, N. M., and W. M. Lee. 1997. Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation. Mol. Cell. Biol. 17:2698-2707.[Abstract]

66. Youngman, E. M., J. L. Brunelle, A. B. Kochaniak, and R. Green. 2004. The active site of the ribosome is composed of two layers of conserved nucleotides with distinct roles in peptide bond formation and peptide release. Cell 117:589-599.[CrossRef][Medline]

67. Zhao, K. N., and I. H. Frazer. 2002. Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. J. Virol. 76:12265-12273.[Abstract/Free Full Text]

68. Zhao, K. N., W. J. Liu, and I. H. Frazer. 2003. Codon usage bias and A+T content variation in human papillomavirus genomes. Virus Res. 98:95-104.[CrossRef][Medline]

69. Zhou, J., W. J. Liu, S. W. Peng, X. Y. Sun, and I. Frazer. 1999. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J. Virol. 73:4972-4982.[Abstract/Free Full Text]

70. Zolotukhin, S., M. Potter, W. W. Hauswirth, J. Guy, and N. Muzyczka. 1996. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:4646-4654.[Abstract]

Molecular and Cellular Biology, October 2005, p. 8643-8655, Vol. 25, No. 19
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.19.8643-8655.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Pre